Related Experiment Video
Updated: Jun 13, 2026

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
Published on: January 22, 2019
Does earlier HIV RNA suppression provide long-term benefits?
Graeme Moyle1, Ralph Demasi, Andrew Hill
1Chelsea and Westminster Hospital, London UK.
Achieving early HIV RNA suppression (<50 copies/ml within 12 weeks) in protease inhibitor-based HAART did not improve long-term viral undetectability compared to later suppression. Seven trials confirm no correlation between early HIV RNA decline dynamics and sustained virological control.
Area of Science:
- Virology
- Immunology
- Clinical Medicine
Background:
- Highly active antiretroviral therapy (HAART) has transformed HIV management.
- Protease inhibitor-based HAART regimens are a cornerstone of treatment.
- Understanding factors influencing long-term virological suppression is crucial for optimizing patient outcomes.
Purpose of the Study:
- To investigate the relationship between the timing of HIV RNA suppression and long-term virological undetectability in patients on protease inhibitor-based HAART.
- To determine if early viral decline dynamics predict sustained viral load control.
Main Methods:
- Analysis of data from the ARTEMIS and TITAN clinical trials.
- Comparison of long-term HIV RNA undetectability rates between patients achieving early (<12 weeks) versus later (12-24 weeks) viral suppression.
- Examination of seven additional large clinical trials to assess correlations between early HIV RNA decline and long-term suppression.
Main Results:
- Patients achieving early HIV RNA suppression (<50 copies/ml within 12 weeks) demonstrated similar rates of long-term viral undetectability compared to those with later suppression (12-24 weeks).
- Analyses across seven other major clinical trials revealed no consistent correlation between the speed of initial HIV RNA decline and sustained virological suppression.
Conclusions:
- The timing of achieving HIV RNA suppression within the first 24 weeks of protease inhibitor-based HAART does not appear to significantly impact long-term virological control.
- Early viral dynamics in HIV RNA decline are not a reliable predictor of sustained undetectable viral loads.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Inhibitors of Viral Protein Synthesis
Viruses with RNA Genomes
Size and Structure of Viral Genomes
Inhibitors of Virion Maturation and Assembly

